Bank of New York Mellon’s Cue Biopharma CUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-92,207
| Closed | -$174K | – | 4148 |
|
|
2024
Q1 | $174K | Sell |
92,207
-17,146
| -16% | -$32.4K | ﹤0.01% | 3959 |
|
|
2023
Q4 | $289K | Buy |
109,353
+6,341
| +6% | +$16.7K | ﹤0.01% | 3809 |
|
|
2023
Q3 | $237K | Sell |
103,012
-142
| -0.1% | -$327 | ﹤0.01% | 3898 |
|
|
2023
Q2 | $377K | Buy |
103,154
+81,867
| +385% | +$299K | ﹤0.01% | 3728 |
|
|
2023
Q1 | $76K | Hold |
21,287
| – | – | ﹤0.01% | 4113 |
|
|
2022
Q4 | $60.7K | Sell |
21,287
-42
| -0.2% | -$120 | ﹤0.01% | 4206 |
|
|
2022
Q3 | $48K | Sell |
21,329
-10
| -0% | -$23 | ﹤0.01% | 4327 |
|
|
2022
Q2 | $53K | Sell |
21,339
-87,829
| -80% | -$218K | ﹤0.01% | 4332 |
|
|
2022
Q1 | $533K | Buy |
109,168
+2,430
| +2% | +$11.9K | ﹤0.01% | 3667 |
|
|
2021
Q4 | $1.21M | Sell |
106,738
-398
| -0.4% | -$4.5K | ﹤0.01% | 3272 |
|
|
2021
Q3 | $1.56M | Buy |
107,136
+6,558
| +7% | +$95.6K | ﹤0.01% | 3136 |
|
|
2021
Q2 | $1.17M | Sell |
100,578
-9,442
| -9% | -$110K | ﹤0.01% | 3302 |
|
|
2021
Q1 | $1.34M | Sell |
110,020
-4,926
| -4% | -$60.1K | ﹤0.01% | 3164 |
|
|
2020
Q4 | $1.44M | Buy |
114,946
+3,631
| +3% | +$45.4K | ﹤0.01% | 3031 |
|
|
2020
Q3 | $1.68M | Sell |
111,315
-75
| -0.1% | -$1.13K | ﹤0.01% | 2764 |
|
|
2020
Q2 | $2.73M | Buy |
111,390
+36,971
| +50% | +$906K | ﹤0.01% | 2503 |
|
|
2020
Q1 | $1.06M | Buy |
74,419
+8,137
| +12% | +$115K | ﹤0.01% | 2939 |
|
|
2019
Q4 | $1.05M | Buy |
66,282
+10,183
| +18% | +$162K | ﹤0.01% | 3223 |
|
|
2019
Q3 | $473K | Sell |
56,099
-92
| -0.2% | -$776 | ﹤0.01% | 3561 |
|
|
2019
Q2 | $505K | Buy |
56,191
+151
| +0.3% | +$1.36K | ﹤0.01% | 3593 |
|
|
2019
Q1 | $433K | Buy |
56,040
+4,264
| +8% | +$32.9K | ﹤0.01% | 3611 |
|
|
2018
Q4 | $243K | Buy |
51,776
+7,272
| +16% | +$34.1K | ﹤0.01% | 3780 |
|
|
2018
Q3 | $403K | Sell |
44,504
-1
| -0% | -$9 | ﹤0.01% | 3726 |
|
|
2018
Q2 | $527K | Buy |
44,505
+22,229
| +100% | +$263K | ﹤0.01% | 3609 |
|
|
2018
Q1 | $313K | Buy |
+22,276
| New | +$313K | ﹤0.01% | 3772 |
|